Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Kuchynka, Petr ^a   Palecek, Tomas ^a   Masek, Martin ^a   Cerny, Vladimir ^a   Lambert, Lukas ^a   Vitkova, Ivana ^a   Linhart, Ales ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AZATHIOPRINE; BENRALIZUMAB; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GALECTIN; GROWTH DIFFERENTIATION FACTOR; IMATINIB; INOTROPIC AGENT; LENALIDOMIDE; MEPOLIZUMAB; METHYLDOPA; NEUROLEPTIC AGENT; PENTRAXIN; PREDNISONE; SULFONYLUREA; TETANUS TOXOID; TROPONIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ALLERGIC REACTION; ANTIMICROBIAL THERAPY; CARDIAC IMAGING; CARDIOGENIC SHOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CELL ACTIVATION; CELL PROLIFERATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; EOSINOPHIL; EOSINOPHILIA; EOSINOPHILIC MYOCARDITIS; ERYTHROCYTE SEDIMENTATION RATE; EXTRACELLULAR MATRIX; FAINTNESS; FATIGUE; HEART MUSCLE BIOPSY; HEART PALPITATION; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERSENSITIVITY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MYOCARDITIS; MYOFIBROBLAST; PATHOPHYSIOLOGY; REVIEW; SUDDEN CARDIAC DEATH; THORAX PAIN; BIOPSY; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

BIOPSY; EOSINOPHILIA; EOSINOPHILS; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; MYOCARDITIS;

EID: 84958568789     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/2829583     Document Type: Review

References (26)

1. C. M. Oakley and E. G. J. Olsen, "Eosinophilia and heart disease, " British Heart Journal, vol. 39, no. 3, pp. 233-237, 1977.
2. P. E. Séguéla, X. Iriart, P. Acar, M. Montaudon, R. Roudaut, and J. B. Thambo, "Eosinophilic cardiac disease: molecular, clinical and imaging aspects, " Archives of Cardiovascular Diseases, vol. 108, no. 4, pp. 258-268, 2015.
3. P. Akuthota and P. F. Weller, "Spectrum of eosinophilic endorgan manifestations, " Immunology and Allergy Clinics of North America, vol. 35, no. 3, pp. 403-411, 2015.
4. J. Gotlib, "World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management, " American Journal of Hematology, vol. 89, no. 3, pp. 325-337, 2014.
5. A. M. Al Ali, L. P. Straatman, M. F. Allard, and A. P. Ignaszewski, "Eosinophilic myocarditis: case series and review of literature, " Canadian Journal of Cardiology, vol. 22, no. 14, pp. 1233-1237, 2006.
6. B. Maisch and S. Pankuweit, "Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy, " Herz, vol. 37, no. 6, pp. 644-656, 2012.
7. J. J. M. Takkenberg, L. S. C. Czer, M. C. Fishbein et al. , "Eosinophilic myocarditis in patients awaiting heart transplantation, " Critical Care Medicine, vol. 32, no. 3, pp. 714-721, 2004.
8. S. Yoshizawa, T. S. Kato, D. Mancini, and C. C. Marboe, "Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era: investigation of explanted hearts for transplantation, " International Heart Journal, vol. 54, no. 3, pp. 146-148, 2013.
9. M. Cugno, A. V. Marzano, M. Lorini, V. Carbonelli, and A. Tedeschi, "Enhanced tissue factor expression by blood eosinophils frompatients with hypereosinophilia: a possible linkwith thrombosis, " PLoS ONE, vol. 9, no. 11, Article ID e111862, 2014.
10. U. Baandrup, "Eosinophilicmyocarditis, " Herz, vol. 37, no. 8, pp. 849-853, 2012.
11. G. S. Spear, "Eosinophilic explant carditis with eosinophilia:? Hypersensitivity to dobutamine infusion, " Journal of Heart and Lung Transplantation, vol. 14, no. 4, pp. 755-760, 1995.
12. J. Gotlib, "Molecular classification and pathogenesis of eosinophilic disorders: 2005 update, " Acta Haematologica, vol. 114, no. 1, pp. 7-25, 2005.
13. A. T. Masi, G. G. Hunder, J. T. Lie et al. , "The American college of rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis), " Arthritis and Rheumatism, vol. 33, no. 8, pp. 1094-1100, 1990.
14. A. Greco, M. I. Rizzo, A. De Virgilio et al. , "Churg-Strauss syndrome, " Autoimmunity Reviews, vol. 14, no. 4, pp. 341-348, 2015.
15. P. U. Ogbogu, B. S. Bochner, J. H. Butterfield et al. , "Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy, " Journal of Allergy and Clinical Immunology, vol. 124, no. 6, pp. 1319. e3-1325. e3, 2009.
16. S. Kawano, J. Kato, N. Kawano et al. , "Clinical features and outcomes of eosinophilic myocarditis patients treated with prednisolone at a single institution over a 27-year period, " Internal Medicine, vol. 50, no. 9, pp. 975-981, 2011.
17. A. L. P. Caforio, S. Pankuweit, E. Arbustini et al. , "Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, " European Heart Journal, vol. 34, no. 33, pp. 2636-2648, 2013.
18. N. K. Kim, C. Y. Kim, J. H. Kim et al. , "A hypereosinophilic syndrome with cardiac involvement from thrombotic stage to fibrotic stage, " Journal of Cardiovascular Ultrasound, vol. 23, no. 2, pp. 100-102, 2015.
19. S. R. Ommen, J. B. Seward, and A. J. Tajik, "Clinical and echocardiographic features of hypereosinophilic syndromes, " American Journal of Cardiology, vol. 86, no. 1, pp. 110-113, 2000.
20. M. G. Friedrich, U. Sechtem, J. Schulz-Menger et al. , "Cardiovascular magnetic resonance in myocarditis: a JACC white paper, " Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1475-1487, 2009.
21. S. E. Petersen, A. Kardos, and S. Neubauer, "Subendocardial and papillary muscle involvement in a patient with Churg-Strauss syndrome, detected by contrast enhanced cardiovascular magnetic resonance, " Heart, vol. 91, no. 1, article e9, 2005.
22. J. Marmursztejn, L. Guillevin, R. Trebossen et al. , "Churgstrauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients, " Rheumatology, vol. 52, no. 4, Article IDkes155, pp. 642-650, 2013.
23. T. Miszalski-Jamka, W. Szczeklik, B. Sokoowska et al. , "Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), " Journal of the American College of Cardiology, vol. 65, no. 1, pp. 103-105, 2015.
24. M. E. Rothenberg, A. D. Klion, F. E. Roufosse et al. , "Treatment of patients with the hypereosinophilic syndrome with mepolizumab, " The New England Journal of Medicine, vol. 358, no. 12, pp. 1215-1228, 2008.
25. T. Yanagisawa, T. Inomata, I. Watanabe et al. , "Clinical significance of corticosteroid therapy for eosinophilic myocarditis, " International Heart Journal, vol. 52, no. 2, pp. 110-113, 2011.
26. F. Legrand and A. D. Klion, "Biologic therapies targeting eosinophils: current status and future prospects, " The Journal of Allergy and Clinical Immunology: In Practice, vol. 3, no. 2, pp. 167-174, 2015.